Natera, Inc. ( NTRA) - Stock Earnings
NTRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
NTRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 47.3 million USD | 665.5 million USD |
| 2026Q1 | -85.1 million USD | 696.6 million USD |
| 2026Q2 | -67.0 million USD | 752.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NTRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -434.8 million USD | 1.1 billion USD |
| 2024 | -190.4 million USD | 1.7 billion USD |
| 2025 | -208.2 million USD | 2.3 billion USD |
| 2026 Est. | — | — |
NTRA
Price: $400.71
52 week price:
Earnings Per Share: -1.31 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 659200
Ebitda: -23.3 millionMarket Capitalization: 57.4 billion